Improvement of Clinical Staging in Cervical Cancer with Serum Squamous Cell Carcinoma Antigen and CA 125 Determinations
Authors:
- 1 March 1997
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 64 (3) , 473-476
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Squamous Cell Carcinoma Antigen: Clinical Utility in Squamous Cell Carcinoma of the Uterine CervixGynecologic Oncology, 1994
- The Prognostic Value of TPA and SCC in Squamous Cell Carcinoma of the CervixGynecologic Oncology, 1994
- Tumor markers CA 125, carcinoembryonic antigen and tumor-associated trypsin inhibitor in patients with cervical adenocarcinomaGynecologic Oncology, 1990
- Cancer of the uterine cervix: Sensitivity and specificity of serum squamous cell carcinoma antigen determinationsGynecologic Oncology, 1990
- Prognostic significance of parametrial extension in patients with cervical carcinoma stages IB, IIA, and IIB. A study of 628 cases treated by radical hysterectomy and lymphadenectomy with or without postoperative irradiationCancer, 1984
- Vascular invasion in stage I carcinoma of the cervixCancer, 1984
- Primary surgical treatment in one hundred ninety-five cases of Stage IB carcinoma of the cervixAmerican Journal of Obstetrics and Gynecology, 1982
- Histological criteria for the prognosis in patients with operated squamous cell carcinoma of the cervixGynecologic Oncology, 1982
- Is pelvic radiation beneficial in the postoperative management of stage Ib squamous cell carcinoma of the cervix with pelvic node metastasis treated by radical hysterectomy and pelvic lymphadenectomy?A report from the presidential panel at the 1979 Annual Meeting of the Society of Gynecologic OncologistsGynecologic Oncology, 1980
- Results and complications of operative staging in cervical cancer: Experience of the Gynecologic Oncology GroupGynecologic Oncology, 1980